Interferon pathway in SLE: one key to unlocking the mystery of the diseaseLars Rönnblom, Dag Leonard|Lupus Science & Medicine|2019Cited by 338
Systemic lupus erythematosus and the type I interferon systemLars Rönnblom, Gunnar V. Alm|Arthritis Research|2003Cited by 160
Pharmacokinetics, tolerability, and preliminary efficacy of paquinimod (ABR‐215757), a new quinoline‐3‐carboxamide derivative: Studies in lupus‐prone mice and a multicenter, randomized, double‐blind, placebo‐controlled, repeat‐dose, dose‐ranging study in patients with systemic lupus erythematosusAnders Bengtsson, Tomas Leanderson, Christian Lood et al.|Arthritis & Rheumatism|2011Cited by 124
Type I interferons in host defence and inflammatory diseasesMary K. Crow, Lars Rönnblom|Lupus Science & Medicine|2019Cited by 120
Systemic Lupus Erythematosus Immune Complexes Increase the Expression of SLAM Family Members CD319 (CRACC) and CD229 (LY-9) on Plasmacytoid Dendritic Cells and CD319 on CD56dim NK CellsNiklas Hagberg, Lars Rönnblom|The Journal of Immunology|2013Cited by 37